Vaxxa AB (NGM:VAXXA)
Sweden · Delayed Price · Currency is SEK 0.4460
+0.0050 (1.13%)
At close: Sep 30, 2026
Vaxxa AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 84.75 | 75.05 | 81.65 | 52.92 | - | 4.75 | |
Revenue Growth | 21.09% | -8.09% | 54.29% | - | - | 690.54% |
Cost of Revenue | 84.15 | 76.04 | 77.57 | 53.46 | 0.54 | 4.8 |
Gross Profit | 0.59 | -0.99 | 4.09 | -0.54 | -0.54 | -0.05 |
Selling, General & Admin | 9.19 | 8.67 | 4.86 | 5.25 | 1.78 | 5.6 |
Other Operating Expenses | -1.31 | -2.57 | -3.13 | -2.71 | 0.03 | -0.37 |
Operating Expenses | 10.11 | 8.39 | 3.79 | 3.78 | 1.81 | 7.86 |
Operating Income | -9.52 | -9.38 | 0.3 | -4.32 | -2.35 | -7.91 |
Interest Expense | -0.22 | -0.05 | -0.15 | -0.66 | -0.24 | -4.67 |
Interest & Investment Income | - | 0.08 | 0.24 | 0.02 | - | 0.03 |
Earnings From Equity Investments | - | - | - | - | -38.94 | - |
Other Non Operating Income (Expenses) | - | - | - | -0.14 | -0.4 | - |
Pretax Income | -9.73 | -9.35 | 0.39 | -5.1 | -41.93 | -12.55 |
Income Tax Expense | - | - | - | - | - | 0.28 |
Net Income | -9.73 | -9.35 | 0.39 | -5.1 | -41.93 | -12.83 |
Net Income to Common | -9.73 | -9.35 | 0.39 | -5.1 | -41.93 | -12.83 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 40 | 43 | 39 | 25 | 2 | 1 |
Shares Outstanding (Diluted) | 40 | 43 | 39 | 25 | 2 | 1 |
Shares Change | -12.87% | 11.34% | 52.28% | 1295.73% | 191.14% | 86.97% |
EPS (Basic) | -0.24 | -0.22 | 0.01 | -0.20 | -22.97 | -20.46 |
EPS (Diluted) | -0.24 | -0.22 | 0.01 | -0.20 | -22.97 | -20.46 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | - | - | - | -2.29 | -6.82 |
Free Cash Flow Per Share | - | - | - | - | -1.25 | -10.88 |
Gross Margin | 0.70% | -1.32% | 5.00% | -1.01% | - | -1.14% |
Operating Margin | -11.23% | -12.50% | 0.37% | -8.16% | - | -166.68% |
Profit Margin | -11.49% | -12.46% | 0.47% | -9.63% | - | -270.27% |
Free Cash Flow Margin | - | - | - | - | - | -143.64% |
EBITDA | -7.29 | -7.09 | 2.35 | -1.82 | 8.4 | -5.29 |
EBITDA Margin | -8.61% | -9.45% | 2.88% | -3.44% | - | -111.45% |
D&A For EBITDA | 2.23 | 2.29 | 2.05 | 2.5 | 10.75 | 2.62 |
EBIT | -9.52 | -9.38 | 0.3 | -4.32 | -2.35 | -7.91 |
EBIT Margin | -11.23% | -12.50% | 0.37% | -8.16% | - | -166.68% |
Revenue as Reported | 86.05 | 77.62 | 84.78 | 55.64 | -0.03 | 5.11 |